Patient preferences for treatment of chronic rhinosinusitis with nasal polyps.
Choosing between revision endoscopic sinus surgery (ESS) versus biologic therapy for recurrent chronic rhinosinusitis with nasal polyposis (CRSwNP) is a complex, multifaceted decision that involves not only clinical and financial factors but also patient preferences. Currently, there are no quantitative studies investigating patient preferences for CRSwNP treatment options. Increased awareness of patient-centered approaches to treatment warrant further investigation.
Authors
- Michael B. Wallace (ORCID: https://orcid.org/0000-0002-6446-5785)
- J Sutphin
- Ralph Abi Hachem (ORCID: https://orcid.org/0009-0000-4007-8505)
- Arijita Deb (ORCID: https://orcid.org/0000-0002-4570-0364)
- Jared Silver (ORCID: https://orcid.org/0000-0002-7838-0985)
- Somtochi Okafor (ORCID: https://orcid.org/0000-0002-5609-0717)
- Shelby D. Reed (ORCID: https://orcid.org/0000-0002-7654-4464)
- Jyh‐Chin Yang (ORCID: https://orcid.org/0000-0003-4219-0685)
- D. Jang (ORCID: https://orcid.org/0000-0003-4239-3781)
Institutions
- Duke University (US)
- Providence College (US)
- Clinical Research Institute (US)
- Durham VA Medical Center (US)
Publication Details
- Journal
- PubMed
- Published
- 2025-04-01
- DOI
- https://doi.org/10.4193/rhin24.475
- Citations
- 1
- Primary Topic
- Sinusitis and nasal conditions
- Type
- article
- Field-Weighted Citation Impact
- 1.85